These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18639367)

  • 1. The PPAR-gamma Pro12Ala polymorphism and risk of cognitive impairment in a longitudinal study.
    West NA; Haan MN; Morgenstern H
    Neurobiol Aging; 2010 May; 31(5):741-6. PubMed ID: 18639367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the PPAR-gamma2 Pro12Ala polymorphism and ACE inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: evidence from BENEDICT.
    De Cosmo S; Motterlini N; Prudente S; Pellegrini F; Trevisan R; Bossi A; Remuzzi G; Trischitta V; Ruggenenti P;
    Diabetes; 2009 Dec; 58(12):2920-9. PubMed ID: 19720797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive decline and the PPAR-γ Pro12Ala genotype: variation by sex and ethnicity.
    West NA; Baxter J; Bryant LL; Nelson TL
    Age Ageing; 2017 Jan; 46(1):96-100. PubMed ID: 28181642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.
    Lapice E; Monticelli A; Cocozza S; Pinelli M; Cocozza S; Bruzzese D; Riccardi G; Vaccaro O
    J Transl Med; 2015 Mar; 13():85. PubMed ID: 25889595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR-gamma Pro12Ala genotype and risk of cognitive decline in elders.
    Yaffe K; Kanaya AM; Lindquist K; Hsueh WC; Cummings SR; Beamer B; Newman A; Rosano C; Li R; Harris T;
    Neurobiol Aging; 2008 Jan; 29(1):78-83. PubMed ID: 17052804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pro12Ala polymorphism in the PPAR-γ2 gene is not associated with an increased risk of NAFLD in Iranian patients with type 2 diabetes mellitus.
    Saremi L; Lotfipanah S; Mohammadi M; Hosseinzadeh H; Fathi-Kazerooni M; Johari B; Saltanatpour Z
    Cell Mol Biol Lett; 2019; 24():12. PubMed ID: 30923554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity modifies the influence of apolipoprotein E ε4 allele and type 2 diabetes on dementia and cognitive impairment among older Mexican Americans.
    Shih IF; Paul K; Haan M; Yu Y; Ritz B
    Alzheimers Dement; 2018 Jan; 14(1):1-9. PubMed ID: 28692819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body adiposity in late life and risk of dementia or cognitive impairment in a longitudinal community-based study.
    West NA; Haan MN
    J Gerontol A Biol Sci Med Sci; 2009 Jan; 64(1):103-9. PubMed ID: 19168781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans.
    Mayeda ER; Haan MN; Kanaya AM; Yaffe K; Neuhaus J
    Diabetes Care; 2013 Sep; 36(9):2600-6. PubMed ID: 23514732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR-gamma2 pro12Ala polymorphism is associated with post-challenge abnormalities of glucose homeostasis in children and adolescents with obesity.
    Jermendy A; Körner A; Kovács M; Madácsy L; Cseh K
    J Pediatr Endocrinol Metab; 2011; 24(1-2):55-9. PubMed ID: 21528816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARG Pro12Ala genotype and risk of cognitive decline in elders? Maybe with diabetes.
    Johnson W; Harris SE; Starr JM; Whalley LJ; Deary IJ
    Neurosci Lett; 2008 Mar; 434(1):50-5. PubMed ID: 18280041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro12Ala polymorphism of the PPARgamma2 locus modulates the relationship between energy intake and body weight in type 2 diabetic patients.
    Vaccaro O; Lapice E; Monticelli A; Giacchetti M; Castaldo I; Galasso R; Pinelli M; Donnarumma G; Rivellese AA; Cocozza S; Riccardi G
    Diabetes Care; 2007 May; 30(5):1156-61. PubMed ID: 17259473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in PPARG is associated with longitudinal change in insulin resistance in Mexican Americans at risk for type 2 diabetes.
    Black MH; Wu J; Takayanagi M; Wang N; Taylor KD; Haritunians T; Trigo E; Lawrence JM; Watanabe RM; Buchanan TA; Xiang AH
    J Clin Endocrinol Metab; 2015 Mar; 100(3):1187-95. PubMed ID: 25584717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
    Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
    J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the Pro12Ala and C1431T variants of PPARG and their haplotypes with susceptibility to Type 2 diabetes.
    Doney ASF; Fischer B; Cecil JE; Boylan K; McGuigan FE; Ralston SH; Morris AD; Palmer CNA
    Diabetologia; 2004 Mar; 47(3):555-558. PubMed ID: 14730381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.